Global Antiviral Immunoglobulin Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Antiviral Immunoglobulin market size was valued at US$ 11581 million in 2025 and is forecast to a readjusted size of US$ 17924 million by 2032 with a CAGR of 6.4% during review period.
Antiviral immunoglobulin refers to a class of biological medicinal products containing specific antibodies used for the prevention (prophylaxis) or treatment of viral diseases, operating on the principle of passive immunization. In 2025,global antiviral immunoglobulin production reached approximately 1,731K Kg, with an average global market price of around USD 6,500 per Kg. A factory gross profit of USD 1,950 per Kg with 30% gross margin. A single line full machine capacity production is around 25K Kg per line per year.The upstream segment is highly dependent on the global human plasma supply chain. Downstream demand is concentrated in hospitals,emergency care and research and specialty clinics. A hepatitis B-positive liver transplant recipient receives HBIG therapy following transplantation to reduce the risk of viral recurrence and graft failure. China isleading due to aggressive expansion of plasma-derived biologics manufacturing, increasing healthcare expenditure, and growing domestic demand for immunotherapy products. while US following due to advanced transplant medicine, high immunoglobulin utilization rates, strong reimbursement systems, and continuous expansion of plasma donation infrastructure.
This report is a detailed and comprehensive analysis for global Antiviral Immunoglobulin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Antiviral Immunoglobulin market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Antiviral Immunoglobulin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Antiviral Immunoglobulin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Antiviral Immunoglobulin market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Antiviral Immunoglobulin market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Antiviral Immunoglobulin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antiviral Immunoglobulin, with price, sales quantity, revenue, and global market share of Antiviral Immunoglobulin from 2021 to 2026.
Chapter 3, the Antiviral Immunoglobulin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antiviral Immunoglobulin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Antiviral Immunoglobulin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antiviral Immunoglobulin.
Chapter 14 and 15, to describe Antiviral Immunoglobulin sales channel, distributors, customers, research findings and conclusion.
Antiviral immunoglobulin refers to a class of biological medicinal products containing specific antibodies used for the prevention (prophylaxis) or treatment of viral diseases, operating on the principle of passive immunization. In 2025,global antiviral immunoglobulin production reached approximately 1,731K Kg, with an average global market price of around USD 6,500 per Kg. A factory gross profit of USD 1,950 per Kg with 30% gross margin. A single line full machine capacity production is around 25K Kg per line per year.The upstream segment is highly dependent on the global human plasma supply chain. Downstream demand is concentrated in hospitals,emergency care and research and specialty clinics. A hepatitis B-positive liver transplant recipient receives HBIG therapy following transplantation to reduce the risk of viral recurrence and graft failure. China isleading due to aggressive expansion of plasma-derived biologics manufacturing, increasing healthcare expenditure, and growing domestic demand for immunotherapy products. while US following due to advanced transplant medicine, high immunoglobulin utilization rates, strong reimbursement systems, and continuous expansion of plasma donation infrastructure.
This report is a detailed and comprehensive analysis for global Antiviral Immunoglobulin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Antiviral Immunoglobulin market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Antiviral Immunoglobulin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Antiviral Immunoglobulin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/kg), 2021-2032
Global Antiviral Immunoglobulin market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Antiviral Immunoglobulin
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Antiviral Immunoglobulin market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Human Plasma Derived Polyclonal
- Hyperimmune Specific Globulin
- Recombinant Monoclonal Antibody (mAb)
- Animal Derived (Equine/Ovine)
- Others
- Standard Fractionated Grade (90%–95%)
- Clinical High Purity Grade (96%–98%)
- Ultra Purified Specialty Grade(99%)
- Transplantation
- Infectious Disease Prophylaxis
- Immunodeficiency
- Neurology (Autoimmune)
- Others
- Hospitals
- Specialty Clinics
- Home Care
- Others
- ADMA Biologics (US)
- AstraZeneca (UK/Sweden)
- Bharat Serums & Vaccines (India)
- Biotest (Germany)
- Boya Bio (China)
- China Biologic Products (CNBG) (China)
- CSL Behring (US/Germany)
- Emergent BioSolutions (US)
- GC Pharma (S. Korea)
- Grifols (Spain)
- Hualan Biological (China)
- Intas Pharmaceuticals (India)
- Kamada (Israel)
- Kedrion (Italy)
- LFB Group (France)
- Octapharma (Switzerland)
- Regeneron (US)
- Roche (Switzerland)
- Sanofi (France)
- Shanghai RAAS (China)
- Shuanglin Bio (China)
- SK Plasma (S. Korea)
- Takeda Pharmaceutical (Japan)
- Tiantan Bio (China)
- Weiguang Biological (China)
- Yuanda Shuyang (China)
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Antiviral Immunoglobulin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antiviral Immunoglobulin, with price, sales quantity, revenue, and global market share of Antiviral Immunoglobulin from 2021 to 2026.
Chapter 3, the Antiviral Immunoglobulin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antiviral Immunoglobulin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Antiviral Immunoglobulin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antiviral Immunoglobulin.
Chapter 14 and 15, to describe Antiviral Immunoglobulin sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Antiviral Immunoglobulin Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Human Plasma Derived Polyclonal
1.3.3 Hyperimmune Specific Globulin
1.3.4 Recombinant Monoclonal Antibody (mAb)
1.3.5 Animal Derived (Equine/Ovine)
1.3.6 Others
1.4 Market Analysis by IgG Purity
1.4.1 Overview: Global Antiviral Immunoglobulin Consumption Value by IgG Purity: 2021 Versus 2025 Versus 2032
1.4.2 Standard Fractionated Grade (90%–95%)
1.4.3 Clinical High Purity Grade (96%–98%)
1.4.4 Ultra Purified Specialty Grade(99%)
1.5 Market Analysis by Therapeutic Area
1.5.1 Overview: Global Antiviral Immunoglobulin Consumption Value by Therapeutic Area: 2021 Versus 2025 Versus 2032
1.5.2 Transplantation
1.5.3 Infectious Disease Prophylaxis
1.5.4 Immunodeficiency
1.5.5 Neurology (Autoimmune)
1.5.6 Others
1.6 Market Analysis by Application
1.6.1 Overview: Global Antiviral Immunoglobulin Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospitals
1.6.3 Specialty Clinics
1.6.4 Home Care
1.6.5 Others
1.7 Global Antiviral Immunoglobulin Market Size & Forecast
1.7.1 Global Antiviral Immunoglobulin Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Antiviral Immunoglobulin Sales Quantity (2021-2032)
1.7.3 Global Antiviral Immunoglobulin Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 ADMA Biologics (US)
2.1.1 ADMA Biologics (US) Details
2.1.2 ADMA Biologics (US) Major Business
2.1.3 ADMA Biologics (US) Antiviral Immunoglobulin Product and Services
2.1.4 ADMA Biologics (US) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 ADMA Biologics (US) Recent Developments/Updates
2.2 AstraZeneca (UK/Sweden)
2.2.1 AstraZeneca (UK/Sweden) Details
2.2.2 AstraZeneca (UK/Sweden) Major Business
2.2.3 AstraZeneca (UK/Sweden) Antiviral Immunoglobulin Product and Services
2.2.4 AstraZeneca (UK/Sweden) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 AstraZeneca (UK/Sweden) Recent Developments/Updates
2.3 Bharat Serums & Vaccines (India)
2.3.1 Bharat Serums & Vaccines (India) Details
2.3.2 Bharat Serums & Vaccines (India) Major Business
2.3.3 Bharat Serums & Vaccines (India) Antiviral Immunoglobulin Product and Services
2.3.4 Bharat Serums & Vaccines (India) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Bharat Serums & Vaccines (India) Recent Developments/Updates
2.4 Biotest (Germany)
2.4.1 Biotest (Germany) Details
2.4.2 Biotest (Germany) Major Business
2.4.3 Biotest (Germany) Antiviral Immunoglobulin Product and Services
2.4.4 Biotest (Germany) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Biotest (Germany) Recent Developments/Updates
2.5 Boya Bio (China)
2.5.1 Boya Bio (China) Details
2.5.2 Boya Bio (China) Major Business
2.5.3 Boya Bio (China) Antiviral Immunoglobulin Product and Services
2.5.4 Boya Bio (China) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Boya Bio (China) Recent Developments/Updates
2.6 China Biologic Products (CNBG) (China)
2.6.1 China Biologic Products (CNBG) (China) Details
2.6.2 China Biologic Products (CNBG) (China) Major Business
2.6.3 China Biologic Products (CNBG) (China) Antiviral Immunoglobulin Product and Services
2.6.4 China Biologic Products (CNBG) (China) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 China Biologic Products (CNBG) (China) Recent Developments/Updates
2.7 CSL Behring (US/Germany)
2.7.1 CSL Behring (US/Germany) Details
2.7.2 CSL Behring (US/Germany) Major Business
2.7.3 CSL Behring (US/Germany) Antiviral Immunoglobulin Product and Services
2.7.4 CSL Behring (US/Germany) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 CSL Behring (US/Germany) Recent Developments/Updates
2.8 Emergent BioSolutions (US)
2.8.1 Emergent BioSolutions (US) Details
2.8.2 Emergent BioSolutions (US) Major Business
2.8.3 Emergent BioSolutions (US) Antiviral Immunoglobulin Product and Services
2.8.4 Emergent BioSolutions (US) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Emergent BioSolutions (US) Recent Developments/Updates
2.9 GC Pharma (S. Korea)
2.9.1 GC Pharma (S. Korea) Details
2.9.2 GC Pharma (S. Korea) Major Business
2.9.3 GC Pharma (S. Korea) Antiviral Immunoglobulin Product and Services
2.9.4 GC Pharma (S. Korea) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 GC Pharma (S. Korea) Recent Developments/Updates
2.10 Grifols (Spain)
2.10.1 Grifols (Spain) Details
2.10.2 Grifols (Spain) Major Business
2.10.3 Grifols (Spain) Antiviral Immunoglobulin Product and Services
2.10.4 Grifols (Spain) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Grifols (Spain) Recent Developments/Updates
2.11 Hualan Biological (China)
2.11.1 Hualan Biological (China) Details
2.11.2 Hualan Biological (China) Major Business
2.11.3 Hualan Biological (China) Antiviral Immunoglobulin Product and Services
2.11.4 Hualan Biological (China) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Hualan Biological (China) Recent Developments/Updates
2.12 Intas Pharmaceuticals (India)
2.12.1 Intas Pharmaceuticals (India) Details
2.12.2 Intas Pharmaceuticals (India) Major Business
2.12.3 Intas Pharmaceuticals (India) Antiviral Immunoglobulin Product and Services
2.12.4 Intas Pharmaceuticals (India) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Intas Pharmaceuticals (India) Recent Developments/Updates
2.13 Kamada (Israel)
2.13.1 Kamada (Israel) Details
2.13.2 Kamada (Israel) Major Business
2.13.3 Kamada (Israel) Antiviral Immunoglobulin Product and Services
2.13.4 Kamada (Israel) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Kamada (Israel) Recent Developments/Updates
2.14 Kedrion (Italy)
2.14.1 Kedrion (Italy) Details
2.14.2 Kedrion (Italy) Major Business
2.14.3 Kedrion (Italy) Antiviral Immunoglobulin Product and Services
2.14.4 Kedrion (Italy) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Kedrion (Italy) Recent Developments/Updates
2.15 LFB Group (France)
2.15.1 LFB Group (France) Details
2.15.2 LFB Group (France) Major Business
2.15.3 LFB Group (France) Antiviral Immunoglobulin Product and Services
2.15.4 LFB Group (France) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 LFB Group (France) Recent Developments/Updates
2.16 Octapharma (Switzerland)
2.16.1 Octapharma (Switzerland) Details
2.16.2 Octapharma (Switzerland) Major Business
2.16.3 Octapharma (Switzerland) Antiviral Immunoglobulin Product and Services
2.16.4 Octapharma (Switzerland) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Octapharma (Switzerland) Recent Developments/Updates
2.17 Regeneron (US)
2.17.1 Regeneron (US) Details
2.17.2 Regeneron (US) Major Business
2.17.3 Regeneron (US) Antiviral Immunoglobulin Product and Services
2.17.4 Regeneron (US) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Regeneron (US) Recent Developments/Updates
2.18 Roche (Switzerland)
2.18.1 Roche (Switzerland) Details
2.18.2 Roche (Switzerland) Major Business
2.18.3 Roche (Switzerland) Antiviral Immunoglobulin Product and Services
2.18.4 Roche (Switzerland) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Roche (Switzerland) Recent Developments/Updates
2.19 Sanofi (France)
2.19.1 Sanofi (France) Details
2.19.2 Sanofi (France) Major Business
2.19.3 Sanofi (France) Antiviral Immunoglobulin Product and Services
2.19.4 Sanofi (France) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Sanofi (France) Recent Developments/Updates
2.20 Shanghai RAAS (China)
2.20.1 Shanghai RAAS (China) Details
2.20.2 Shanghai RAAS (China) Major Business
2.20.3 Shanghai RAAS (China) Antiviral Immunoglobulin Product and Services
2.20.4 Shanghai RAAS (China) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Shanghai RAAS (China) Recent Developments/Updates
2.21 Shuanglin Bio (China)
2.21.1 Shuanglin Bio (China) Details
2.21.2 Shuanglin Bio (China) Major Business
2.21.3 Shuanglin Bio (China) Antiviral Immunoglobulin Product and Services
2.21.4 Shuanglin Bio (China) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Shuanglin Bio (China) Recent Developments/Updates
2.22 SK Plasma (S. Korea)
2.22.1 SK Plasma (S. Korea) Details
2.22.2 SK Plasma (S. Korea) Major Business
2.22.3 SK Plasma (S. Korea) Antiviral Immunoglobulin Product and Services
2.22.4 SK Plasma (S. Korea) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 SK Plasma (S. Korea) Recent Developments/Updates
2.23 Takeda Pharmaceutical (Japan)
2.23.1 Takeda Pharmaceutical (Japan) Details
2.23.2 Takeda Pharmaceutical (Japan) Major Business
2.23.3 Takeda Pharmaceutical (Japan) Antiviral Immunoglobulin Product and Services
2.23.4 Takeda Pharmaceutical (Japan) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Takeda Pharmaceutical (Japan) Recent Developments/Updates
2.24 Tiantan Bio (China)
2.24.1 Tiantan Bio (China) Details
2.24.2 Tiantan Bio (China) Major Business
2.24.3 Tiantan Bio (China) Antiviral Immunoglobulin Product and Services
2.24.4 Tiantan Bio (China) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Tiantan Bio (China) Recent Developments/Updates
2.25 Weiguang Biological (China)
2.25.1 Weiguang Biological (China) Details
2.25.2 Weiguang Biological (China) Major Business
2.25.3 Weiguang Biological (China) Antiviral Immunoglobulin Product and Services
2.25.4 Weiguang Biological (China) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 Weiguang Biological (China) Recent Developments/Updates
2.26 Yuanda Shuyang (China)
2.26.1 Yuanda Shuyang (China) Details
2.26.2 Yuanda Shuyang (China) Major Business
2.26.3 Yuanda Shuyang (China) Antiviral Immunoglobulin Product and Services
2.26.4 Yuanda Shuyang (China) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 Yuanda Shuyang (China) Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANTIVIRAL IMMUNOGLOBULIN BY MANUFACTURER
3.1 Global Antiviral Immunoglobulin Sales Quantity by Manufacturer (2021-2026)
3.2 Global Antiviral Immunoglobulin Revenue by Manufacturer (2021-2026)
3.3 Global Antiviral Immunoglobulin Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Antiviral Immunoglobulin by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Antiviral Immunoglobulin Manufacturer Market Share in 2025
3.4.3 Top 6 Antiviral Immunoglobulin Manufacturer Market Share in 2025
3.5 Antiviral Immunoglobulin Market: Overall Company Footprint Analysis
3.5.1 Antiviral Immunoglobulin Market: Region Footprint
3.5.2 Antiviral Immunoglobulin Market: Company Product Type Footprint
3.5.3 Antiviral Immunoglobulin Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Antiviral Immunoglobulin Market Size by Region
4.1.1 Global Antiviral Immunoglobulin Sales Quantity by Region (2021-2032)
4.1.2 Global Antiviral Immunoglobulin Consumption Value by Region (2021-2032)
4.1.3 Global Antiviral Immunoglobulin Average Price by Region (2021-2032)
4.2 North America Antiviral Immunoglobulin Consumption Value (2021-2032)
4.3 Europe Antiviral Immunoglobulin Consumption Value (2021-2032)
4.4 Asia-Pacific Antiviral Immunoglobulin Consumption Value (2021-2032)
4.5 South America Antiviral Immunoglobulin Consumption Value (2021-2032)
4.6 Middle East & Africa Antiviral Immunoglobulin Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Antiviral Immunoglobulin Sales Quantity by Type (2021-2032)
5.2 Global Antiviral Immunoglobulin Consumption Value by Type (2021-2032)
5.3 Global Antiviral Immunoglobulin Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Antiviral Immunoglobulin Sales Quantity by Application (2021-2032)
6.2 Global Antiviral Immunoglobulin Consumption Value by Application (2021-2032)
6.3 Global Antiviral Immunoglobulin Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Antiviral Immunoglobulin Sales Quantity by Type (2021-2032)
7.2 North America Antiviral Immunoglobulin Sales Quantity by Application (2021-2032)
7.3 North America Antiviral Immunoglobulin Market Size by Country
7.3.1 North America Antiviral Immunoglobulin Sales Quantity by Country (2021-2032)
7.3.2 North America Antiviral Immunoglobulin Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Antiviral Immunoglobulin Sales Quantity by Type (2021-2032)
8.2 Europe Antiviral Immunoglobulin Sales Quantity by Application (2021-2032)
8.3 Europe Antiviral Immunoglobulin Market Size by Country
8.3.1 Europe Antiviral Immunoglobulin Sales Quantity by Country (2021-2032)
8.3.2 Europe Antiviral Immunoglobulin Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Antiviral Immunoglobulin Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Antiviral Immunoglobulin Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Antiviral Immunoglobulin Market Size by Region
9.3.1 Asia-Pacific Antiviral Immunoglobulin Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Antiviral Immunoglobulin Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Antiviral Immunoglobulin Sales Quantity by Type (2021-2032)
10.2 South America Antiviral Immunoglobulin Sales Quantity by Application (2021-2032)
10.3 South America Antiviral Immunoglobulin Market Size by Country
10.3.1 South America Antiviral Immunoglobulin Sales Quantity by Country (2021-2032)
10.3.2 South America Antiviral Immunoglobulin Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Antiviral Immunoglobulin Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Antiviral Immunoglobulin Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Antiviral Immunoglobulin Market Size by Country
11.3.1 Middle East & Africa Antiviral Immunoglobulin Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Antiviral Immunoglobulin Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Antiviral Immunoglobulin Market Drivers
12.2 Antiviral Immunoglobulin Market Restraints
12.3 Antiviral Immunoglobulin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Antiviral Immunoglobulin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Antiviral Immunoglobulin
13.3 Antiviral Immunoglobulin Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Antiviral Immunoglobulin Typical Distributors
14.3 Antiviral Immunoglobulin Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Antiviral Immunoglobulin Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Human Plasma Derived Polyclonal
1.3.3 Hyperimmune Specific Globulin
1.3.4 Recombinant Monoclonal Antibody (mAb)
1.3.5 Animal Derived (Equine/Ovine)
1.3.6 Others
1.4 Market Analysis by IgG Purity
1.4.1 Overview: Global Antiviral Immunoglobulin Consumption Value by IgG Purity: 2021 Versus 2025 Versus 2032
1.4.2 Standard Fractionated Grade (90%–95%)
1.4.3 Clinical High Purity Grade (96%–98%)
1.4.4 Ultra Purified Specialty Grade(99%)
1.5 Market Analysis by Therapeutic Area
1.5.1 Overview: Global Antiviral Immunoglobulin Consumption Value by Therapeutic Area: 2021 Versus 2025 Versus 2032
1.5.2 Transplantation
1.5.3 Infectious Disease Prophylaxis
1.5.4 Immunodeficiency
1.5.5 Neurology (Autoimmune)
1.5.6 Others
1.6 Market Analysis by Application
1.6.1 Overview: Global Antiviral Immunoglobulin Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospitals
1.6.3 Specialty Clinics
1.6.4 Home Care
1.6.5 Others
1.7 Global Antiviral Immunoglobulin Market Size & Forecast
1.7.1 Global Antiviral Immunoglobulin Consumption Value (2021 & 2025 & 2032)
1.7.2 Global Antiviral Immunoglobulin Sales Quantity (2021-2032)
1.7.3 Global Antiviral Immunoglobulin Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 ADMA Biologics (US)
2.1.1 ADMA Biologics (US) Details
2.1.2 ADMA Biologics (US) Major Business
2.1.3 ADMA Biologics (US) Antiviral Immunoglobulin Product and Services
2.1.4 ADMA Biologics (US) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 ADMA Biologics (US) Recent Developments/Updates
2.2 AstraZeneca (UK/Sweden)
2.2.1 AstraZeneca (UK/Sweden) Details
2.2.2 AstraZeneca (UK/Sweden) Major Business
2.2.3 AstraZeneca (UK/Sweden) Antiviral Immunoglobulin Product and Services
2.2.4 AstraZeneca (UK/Sweden) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 AstraZeneca (UK/Sweden) Recent Developments/Updates
2.3 Bharat Serums & Vaccines (India)
2.3.1 Bharat Serums & Vaccines (India) Details
2.3.2 Bharat Serums & Vaccines (India) Major Business
2.3.3 Bharat Serums & Vaccines (India) Antiviral Immunoglobulin Product and Services
2.3.4 Bharat Serums & Vaccines (India) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Bharat Serums & Vaccines (India) Recent Developments/Updates
2.4 Biotest (Germany)
2.4.1 Biotest (Germany) Details
2.4.2 Biotest (Germany) Major Business
2.4.3 Biotest (Germany) Antiviral Immunoglobulin Product and Services
2.4.4 Biotest (Germany) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Biotest (Germany) Recent Developments/Updates
2.5 Boya Bio (China)
2.5.1 Boya Bio (China) Details
2.5.2 Boya Bio (China) Major Business
2.5.3 Boya Bio (China) Antiviral Immunoglobulin Product and Services
2.5.4 Boya Bio (China) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Boya Bio (China) Recent Developments/Updates
2.6 China Biologic Products (CNBG) (China)
2.6.1 China Biologic Products (CNBG) (China) Details
2.6.2 China Biologic Products (CNBG) (China) Major Business
2.6.3 China Biologic Products (CNBG) (China) Antiviral Immunoglobulin Product and Services
2.6.4 China Biologic Products (CNBG) (China) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 China Biologic Products (CNBG) (China) Recent Developments/Updates
2.7 CSL Behring (US/Germany)
2.7.1 CSL Behring (US/Germany) Details
2.7.2 CSL Behring (US/Germany) Major Business
2.7.3 CSL Behring (US/Germany) Antiviral Immunoglobulin Product and Services
2.7.4 CSL Behring (US/Germany) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 CSL Behring (US/Germany) Recent Developments/Updates
2.8 Emergent BioSolutions (US)
2.8.1 Emergent BioSolutions (US) Details
2.8.2 Emergent BioSolutions (US) Major Business
2.8.3 Emergent BioSolutions (US) Antiviral Immunoglobulin Product and Services
2.8.4 Emergent BioSolutions (US) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Emergent BioSolutions (US) Recent Developments/Updates
2.9 GC Pharma (S. Korea)
2.9.1 GC Pharma (S. Korea) Details
2.9.2 GC Pharma (S. Korea) Major Business
2.9.3 GC Pharma (S. Korea) Antiviral Immunoglobulin Product and Services
2.9.4 GC Pharma (S. Korea) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 GC Pharma (S. Korea) Recent Developments/Updates
2.10 Grifols (Spain)
2.10.1 Grifols (Spain) Details
2.10.2 Grifols (Spain) Major Business
2.10.3 Grifols (Spain) Antiviral Immunoglobulin Product and Services
2.10.4 Grifols (Spain) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Grifols (Spain) Recent Developments/Updates
2.11 Hualan Biological (China)
2.11.1 Hualan Biological (China) Details
2.11.2 Hualan Biological (China) Major Business
2.11.3 Hualan Biological (China) Antiviral Immunoglobulin Product and Services
2.11.4 Hualan Biological (China) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Hualan Biological (China) Recent Developments/Updates
2.12 Intas Pharmaceuticals (India)
2.12.1 Intas Pharmaceuticals (India) Details
2.12.2 Intas Pharmaceuticals (India) Major Business
2.12.3 Intas Pharmaceuticals (India) Antiviral Immunoglobulin Product and Services
2.12.4 Intas Pharmaceuticals (India) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Intas Pharmaceuticals (India) Recent Developments/Updates
2.13 Kamada (Israel)
2.13.1 Kamada (Israel) Details
2.13.2 Kamada (Israel) Major Business
2.13.3 Kamada (Israel) Antiviral Immunoglobulin Product and Services
2.13.4 Kamada (Israel) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Kamada (Israel) Recent Developments/Updates
2.14 Kedrion (Italy)
2.14.1 Kedrion (Italy) Details
2.14.2 Kedrion (Italy) Major Business
2.14.3 Kedrion (Italy) Antiviral Immunoglobulin Product and Services
2.14.4 Kedrion (Italy) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Kedrion (Italy) Recent Developments/Updates
2.15 LFB Group (France)
2.15.1 LFB Group (France) Details
2.15.2 LFB Group (France) Major Business
2.15.3 LFB Group (France) Antiviral Immunoglobulin Product and Services
2.15.4 LFB Group (France) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 LFB Group (France) Recent Developments/Updates
2.16 Octapharma (Switzerland)
2.16.1 Octapharma (Switzerland) Details
2.16.2 Octapharma (Switzerland) Major Business
2.16.3 Octapharma (Switzerland) Antiviral Immunoglobulin Product and Services
2.16.4 Octapharma (Switzerland) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Octapharma (Switzerland) Recent Developments/Updates
2.17 Regeneron (US)
2.17.1 Regeneron (US) Details
2.17.2 Regeneron (US) Major Business
2.17.3 Regeneron (US) Antiviral Immunoglobulin Product and Services
2.17.4 Regeneron (US) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Regeneron (US) Recent Developments/Updates
2.18 Roche (Switzerland)
2.18.1 Roche (Switzerland) Details
2.18.2 Roche (Switzerland) Major Business
2.18.3 Roche (Switzerland) Antiviral Immunoglobulin Product and Services
2.18.4 Roche (Switzerland) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Roche (Switzerland) Recent Developments/Updates
2.19 Sanofi (France)
2.19.1 Sanofi (France) Details
2.19.2 Sanofi (France) Major Business
2.19.3 Sanofi (France) Antiviral Immunoglobulin Product and Services
2.19.4 Sanofi (France) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Sanofi (France) Recent Developments/Updates
2.20 Shanghai RAAS (China)
2.20.1 Shanghai RAAS (China) Details
2.20.2 Shanghai RAAS (China) Major Business
2.20.3 Shanghai RAAS (China) Antiviral Immunoglobulin Product and Services
2.20.4 Shanghai RAAS (China) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Shanghai RAAS (China) Recent Developments/Updates
2.21 Shuanglin Bio (China)
2.21.1 Shuanglin Bio (China) Details
2.21.2 Shuanglin Bio (China) Major Business
2.21.3 Shuanglin Bio (China) Antiviral Immunoglobulin Product and Services
2.21.4 Shuanglin Bio (China) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Shuanglin Bio (China) Recent Developments/Updates
2.22 SK Plasma (S. Korea)
2.22.1 SK Plasma (S. Korea) Details
2.22.2 SK Plasma (S. Korea) Major Business
2.22.3 SK Plasma (S. Korea) Antiviral Immunoglobulin Product and Services
2.22.4 SK Plasma (S. Korea) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 SK Plasma (S. Korea) Recent Developments/Updates
2.23 Takeda Pharmaceutical (Japan)
2.23.1 Takeda Pharmaceutical (Japan) Details
2.23.2 Takeda Pharmaceutical (Japan) Major Business
2.23.3 Takeda Pharmaceutical (Japan) Antiviral Immunoglobulin Product and Services
2.23.4 Takeda Pharmaceutical (Japan) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Takeda Pharmaceutical (Japan) Recent Developments/Updates
2.24 Tiantan Bio (China)
2.24.1 Tiantan Bio (China) Details
2.24.2 Tiantan Bio (China) Major Business
2.24.3 Tiantan Bio (China) Antiviral Immunoglobulin Product and Services
2.24.4 Tiantan Bio (China) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Tiantan Bio (China) Recent Developments/Updates
2.25 Weiguang Biological (China)
2.25.1 Weiguang Biological (China) Details
2.25.2 Weiguang Biological (China) Major Business
2.25.3 Weiguang Biological (China) Antiviral Immunoglobulin Product and Services
2.25.4 Weiguang Biological (China) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 Weiguang Biological (China) Recent Developments/Updates
2.26 Yuanda Shuyang (China)
2.26.1 Yuanda Shuyang (China) Details
2.26.2 Yuanda Shuyang (China) Major Business
2.26.3 Yuanda Shuyang (China) Antiviral Immunoglobulin Product and Services
2.26.4 Yuanda Shuyang (China) Antiviral Immunoglobulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 Yuanda Shuyang (China) Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANTIVIRAL IMMUNOGLOBULIN BY MANUFACTURER
3.1 Global Antiviral Immunoglobulin Sales Quantity by Manufacturer (2021-2026)
3.2 Global Antiviral Immunoglobulin Revenue by Manufacturer (2021-2026)
3.3 Global Antiviral Immunoglobulin Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Antiviral Immunoglobulin by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Antiviral Immunoglobulin Manufacturer Market Share in 2025
3.4.3 Top 6 Antiviral Immunoglobulin Manufacturer Market Share in 2025
3.5 Antiviral Immunoglobulin Market: Overall Company Footprint Analysis
3.5.1 Antiviral Immunoglobulin Market: Region Footprint
3.5.2 Antiviral Immunoglobulin Market: Company Product Type Footprint
3.5.3 Antiviral Immunoglobulin Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Antiviral Immunoglobulin Market Size by Region
4.1.1 Global Antiviral Immunoglobulin Sales Quantity by Region (2021-2032)
4.1.2 Global Antiviral Immunoglobulin Consumption Value by Region (2021-2032)
4.1.3 Global Antiviral Immunoglobulin Average Price by Region (2021-2032)
4.2 North America Antiviral Immunoglobulin Consumption Value (2021-2032)
4.3 Europe Antiviral Immunoglobulin Consumption Value (2021-2032)
4.4 Asia-Pacific Antiviral Immunoglobulin Consumption Value (2021-2032)
4.5 South America Antiviral Immunoglobulin Consumption Value (2021-2032)
4.6 Middle East & Africa Antiviral Immunoglobulin Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Antiviral Immunoglobulin Sales Quantity by Type (2021-2032)
5.2 Global Antiviral Immunoglobulin Consumption Value by Type (2021-2032)
5.3 Global Antiviral Immunoglobulin Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Antiviral Immunoglobulin Sales Quantity by Application (2021-2032)
6.2 Global Antiviral Immunoglobulin Consumption Value by Application (2021-2032)
6.3 Global Antiviral Immunoglobulin Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Antiviral Immunoglobulin Sales Quantity by Type (2021-2032)
7.2 North America Antiviral Immunoglobulin Sales Quantity by Application (2021-2032)
7.3 North America Antiviral Immunoglobulin Market Size by Country
7.3.1 North America Antiviral Immunoglobulin Sales Quantity by Country (2021-2032)
7.3.2 North America Antiviral Immunoglobulin Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Antiviral Immunoglobulin Sales Quantity by Type (2021-2032)
8.2 Europe Antiviral Immunoglobulin Sales Quantity by Application (2021-2032)
8.3 Europe Antiviral Immunoglobulin Market Size by Country
8.3.1 Europe Antiviral Immunoglobulin Sales Quantity by Country (2021-2032)
8.3.2 Europe Antiviral Immunoglobulin Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Antiviral Immunoglobulin Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Antiviral Immunoglobulin Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Antiviral Immunoglobulin Market Size by Region
9.3.1 Asia-Pacific Antiviral Immunoglobulin Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Antiviral Immunoglobulin Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Antiviral Immunoglobulin Sales Quantity by Type (2021-2032)
10.2 South America Antiviral Immunoglobulin Sales Quantity by Application (2021-2032)
10.3 South America Antiviral Immunoglobulin Market Size by Country
10.3.1 South America Antiviral Immunoglobulin Sales Quantity by Country (2021-2032)
10.3.2 South America Antiviral Immunoglobulin Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Antiviral Immunoglobulin Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Antiviral Immunoglobulin Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Antiviral Immunoglobulin Market Size by Country
11.3.1 Middle East & Africa Antiviral Immunoglobulin Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Antiviral Immunoglobulin Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Antiviral Immunoglobulin Market Drivers
12.2 Antiviral Immunoglobulin Market Restraints
12.3 Antiviral Immunoglobulin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Antiviral Immunoglobulin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Antiviral Immunoglobulin
13.3 Antiviral Immunoglobulin Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Antiviral Immunoglobulin Typical Distributors
14.3 Antiviral Immunoglobulin Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Antiviral Immunoglobulin Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Antiviral Immunoglobulin Consumption Value by IgG Purity, (USD Million), 2021 & 2025 & 2032
Table 3. Global Antiviral Immunoglobulin Consumption Value by Therapeutic Area, (USD Million), 2021 & 2025 & 2032
Table 4. Global Antiviral Immunoglobulin Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. ADMA Biologics (US) Basic Information, Manufacturing Base and Competitors
Table 6. ADMA Biologics (US) Major Business
Table 7. ADMA Biologics (US) Antiviral Immunoglobulin Product and Services
Table 8. ADMA Biologics (US) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. ADMA Biologics (US) Recent Developments/Updates
Table 10. AstraZeneca (UK/Sweden) Basic Information, Manufacturing Base and Competitors
Table 11. AstraZeneca (UK/Sweden) Major Business
Table 12. AstraZeneca (UK/Sweden) Antiviral Immunoglobulin Product and Services
Table 13. AstraZeneca (UK/Sweden) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. AstraZeneca (UK/Sweden) Recent Developments/Updates
Table 15. Bharat Serums & Vaccines (India) Basic Information, Manufacturing Base and Competitors
Table 16. Bharat Serums & Vaccines (India) Major Business
Table 17. Bharat Serums & Vaccines (India) Antiviral Immunoglobulin Product and Services
Table 18. Bharat Serums & Vaccines (India) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Bharat Serums & Vaccines (India) Recent Developments/Updates
Table 20. Biotest (Germany) Basic Information, Manufacturing Base and Competitors
Table 21. Biotest (Germany) Major Business
Table 22. Biotest (Germany) Antiviral Immunoglobulin Product and Services
Table 23. Biotest (Germany) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Biotest (Germany) Recent Developments/Updates
Table 25. Boya Bio (China) Basic Information, Manufacturing Base and Competitors
Table 26. Boya Bio (China) Major Business
Table 27. Boya Bio (China) Antiviral Immunoglobulin Product and Services
Table 28. Boya Bio (China) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Boya Bio (China) Recent Developments/Updates
Table 30. China Biologic Products (CNBG) (China) Basic Information, Manufacturing Base and Competitors
Table 31. China Biologic Products (CNBG) (China) Major Business
Table 32. China Biologic Products (CNBG) (China) Antiviral Immunoglobulin Product and Services
Table 33. China Biologic Products (CNBG) (China) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. China Biologic Products (CNBG) (China) Recent Developments/Updates
Table 35. CSL Behring (US/Germany) Basic Information, Manufacturing Base and Competitors
Table 36. CSL Behring (US/Germany) Major Business
Table 37. CSL Behring (US/Germany) Antiviral Immunoglobulin Product and Services
Table 38. CSL Behring (US/Germany) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. CSL Behring (US/Germany) Recent Developments/Updates
Table 40. Emergent BioSolutions (US) Basic Information, Manufacturing Base and Competitors
Table 41. Emergent BioSolutions (US) Major Business
Table 42. Emergent BioSolutions (US) Antiviral Immunoglobulin Product and Services
Table 43. Emergent BioSolutions (US) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Emergent BioSolutions (US) Recent Developments/Updates
Table 45. GC Pharma (S. Korea) Basic Information, Manufacturing Base and Competitors
Table 46. GC Pharma (S. Korea) Major Business
Table 47. GC Pharma (S. Korea) Antiviral Immunoglobulin Product and Services
Table 48. GC Pharma (S. Korea) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. GC Pharma (S. Korea) Recent Developments/Updates
Table 50. Grifols (Spain) Basic Information, Manufacturing Base and Competitors
Table 51. Grifols (Spain) Major Business
Table 52. Grifols (Spain) Antiviral Immunoglobulin Product and Services
Table 53. Grifols (Spain) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Grifols (Spain) Recent Developments/Updates
Table 55. Hualan Biological (China) Basic Information, Manufacturing Base and Competitors
Table 56. Hualan Biological (China) Major Business
Table 57. Hualan Biological (China) Antiviral Immunoglobulin Product and Services
Table 58. Hualan Biological (China) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Hualan Biological (China) Recent Developments/Updates
Table 60. Intas Pharmaceuticals (India) Basic Information, Manufacturing Base and Competitors
Table 61. Intas Pharmaceuticals (India) Major Business
Table 62. Intas Pharmaceuticals (India) Antiviral Immunoglobulin Product and Services
Table 63. Intas Pharmaceuticals (India) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Intas Pharmaceuticals (India) Recent Developments/Updates
Table 65. Kamada (Israel) Basic Information, Manufacturing Base and Competitors
Table 66. Kamada (Israel) Major Business
Table 67. Kamada (Israel) Antiviral Immunoglobulin Product and Services
Table 68. Kamada (Israel) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Kamada (Israel) Recent Developments/Updates
Table 70. Kedrion (Italy) Basic Information, Manufacturing Base and Competitors
Table 71. Kedrion (Italy) Major Business
Table 72. Kedrion (Italy) Antiviral Immunoglobulin Product and Services
Table 73. Kedrion (Italy) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Kedrion (Italy) Recent Developments/Updates
Table 75. LFB Group (France) Basic Information, Manufacturing Base and Competitors
Table 76. LFB Group (France) Major Business
Table 77. LFB Group (France) Antiviral Immunoglobulin Product and Services
Table 78. LFB Group (France) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. LFB Group (France) Recent Developments/Updates
Table 80. Octapharma (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 81. Octapharma (Switzerland) Major Business
Table 82. Octapharma (Switzerland) Antiviral Immunoglobulin Product and Services
Table 83. Octapharma (Switzerland) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Octapharma (Switzerland) Recent Developments/Updates
Table 85. Regeneron (US) Basic Information, Manufacturing Base and Competitors
Table 86. Regeneron (US) Major Business
Table 87. Regeneron (US) Antiviral Immunoglobulin Product and Services
Table 88. Regeneron (US) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Regeneron (US) Recent Developments/Updates
Table 90. Roche (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 91. Roche (Switzerland) Major Business
Table 92. Roche (Switzerland) Antiviral Immunoglobulin Product and Services
Table 93. Roche (Switzerland) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. Roche (Switzerland) Recent Developments/Updates
Table 95. Sanofi (France) Basic Information, Manufacturing Base and Competitors
Table 96. Sanofi (France) Major Business
Table 97. Sanofi (France) Antiviral Immunoglobulin Product and Services
Table 98. Sanofi (France) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 99. Sanofi (France) Recent Developments/Updates
Table 100. Shanghai RAAS (China) Basic Information, Manufacturing Base and Competitors
Table 101. Shanghai RAAS (China) Major Business
Table 102. Shanghai RAAS (China) Antiviral Immunoglobulin Product and Services
Table 103. Shanghai RAAS (China) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Shanghai RAAS (China) Recent Developments/Updates
Table 105. Shuanglin Bio (China) Basic Information, Manufacturing Base and Competitors
Table 106. Shuanglin Bio (China) Major Business
Table 107. Shuanglin Bio (China) Antiviral Immunoglobulin Product and Services
Table 108. Shuanglin Bio (China) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Shuanglin Bio (China) Recent Developments/Updates
Table 110. SK Plasma (S. Korea) Basic Information, Manufacturing Base and Competitors
Table 111. SK Plasma (S. Korea) Major Business
Table 112. SK Plasma (S. Korea) Antiviral Immunoglobulin Product and Services
Table 113. SK Plasma (S. Korea) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. SK Plasma (S. Korea) Recent Developments/Updates
Table 115. Takeda Pharmaceutical (Japan) Basic Information, Manufacturing Base and Competitors
Table 116. Takeda Pharmaceutical (Japan) Major Business
Table 117. Takeda Pharmaceutical (Japan) Antiviral Immunoglobulin Product and Services
Table 118. Takeda Pharmaceutical (Japan) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Takeda Pharmaceutical (Japan) Recent Developments/Updates
Table 120. Tiantan Bio (China) Basic Information, Manufacturing Base and Competitors
Table 121. Tiantan Bio (China) Major Business
Table 122. Tiantan Bio (China) Antiviral Immunoglobulin Product and Services
Table 123. Tiantan Bio (China) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 124. Tiantan Bio (China) Recent Developments/Updates
Table 125. Weiguang Biological (China) Basic Information, Manufacturing Base and Competitors
Table 126. Weiguang Biological (China) Major Business
Table 127. Weiguang Biological (China) Antiviral Immunoglobulin Product and Services
Table 128. Weiguang Biological (China) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 129. Weiguang Biological (China) Recent Developments/Updates
Table 130. Yuanda Shuyang (China) Basic Information, Manufacturing Base and Competitors
Table 131. Yuanda Shuyang (China) Major Business
Table 132. Yuanda Shuyang (China) Antiviral Immunoglobulin Product and Services
Table 133. Yuanda Shuyang (China) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 134. Yuanda Shuyang (China) Recent Developments/Updates
Table 135. Global Antiviral Immunoglobulin Sales Quantity by Manufacturer (2021-2026) & (kg)
Table 136. Global Antiviral Immunoglobulin Revenue by Manufacturer (2021-2026) & (USD Million)
Table 137. Global Antiviral Immunoglobulin Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 138. Market Position of Manufacturers in Antiviral Immunoglobulin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 139. Head Office and Antiviral Immunoglobulin Production Site of Key Manufacturer
Table 140. Antiviral Immunoglobulin Market: Company Product Type Footprint
Table 141. Antiviral Immunoglobulin Market: Company Product Application Footprint
Table 142. Antiviral Immunoglobulin New Market Entrants and Barriers to Market Entry
Table 143. Antiviral Immunoglobulin Mergers, Acquisition, Agreements, and Collaborations
Table 144. Global Antiviral Immunoglobulin Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 145. Global Antiviral Immunoglobulin Sales Quantity by Region (2021-2026) & (kg)
Table 146. Global Antiviral Immunoglobulin Sales Quantity by Region (2027-2032) & (kg)
Table 147. Global Antiviral Immunoglobulin Consumption Value by Region (2021-2026) & (USD Million)
Table 148. Global Antiviral Immunoglobulin Consumption Value by Region (2027-2032) & (USD Million)
Table 149. Global Antiviral Immunoglobulin Average Price by Region (2021-2026) & (US$/kg)
Table 150. Global Antiviral Immunoglobulin Average Price by Region (2027-2032) & (US$/kg)
Table 151. Global Antiviral Immunoglobulin Sales Quantity by Type (2021-2026) & (kg)
Table 152. Global Antiviral Immunoglobulin Sales Quantity by Type (2027-2032) & (kg)
Table 153. Global Antiviral Immunoglobulin Consumption Value by Type (2021-2026) & (USD Million)
Table 154. Global Antiviral Immunoglobulin Consumption Value by Type (2027-2032) & (USD Million)
Table 155. Global Antiviral Immunoglobulin Average Price by Type (2021-2026) & (US$/kg)
Table 156. Global Antiviral Immunoglobulin Average Price by Type (2027-2032) & (US$/kg)
Table 157. Global Antiviral Immunoglobulin Sales Quantity by Application (2021-2026) & (kg)
Table 158. Global Antiviral Immunoglobulin Sales Quantity by Application (2027-2032) & (kg)
Table 159. Global Antiviral Immunoglobulin Consumption Value by Application (2021-2026) & (USD Million)
Table 160. Global Antiviral Immunoglobulin Consumption Value by Application (2027-2032) & (USD Million)
Table 161. Global Antiviral Immunoglobulin Average Price by Application (2021-2026) & (US$/kg)
Table 162. Global Antiviral Immunoglobulin Average Price by Application (2027-2032) & (US$/kg)
Table 163. North America Antiviral Immunoglobulin Sales Quantity by Type (2021-2026) & (kg)
Table 164. North America Antiviral Immunoglobulin Sales Quantity by Type (2027-2032) & (kg)
Table 165. North America Antiviral Immunoglobulin Sales Quantity by Application (2021-2026) & (kg)
Table 166. North America Antiviral Immunoglobulin Sales Quantity by Application (2027-2032) & (kg)
Table 167. North America Antiviral Immunoglobulin Sales Quantity by Country (2021-2026) & (kg)
Table 168. North America Antiviral Immunoglobulin Sales Quantity by Country (2027-2032) & (kg)
Table 169. North America Antiviral Immunoglobulin Consumption Value by Country (2021-2026) & (USD Million)
Table 170. North America Antiviral Immunoglobulin Consumption Value by Country (2027-2032) & (USD Million)
Table 171. Europe Antiviral Immunoglobulin Sales Quantity by Type (2021-2026) & (kg)
Table 172. Europe Antiviral Immunoglobulin Sales Quantity by Type (2027-2032) & (kg)
Table 173. Europe Antiviral Immunoglobulin Sales Quantity by Application (2021-2026) & (kg)
Table 174. Europe Antiviral Immunoglobulin Sales Quantity by Application (2027-2032) & (kg)
Table 175. Europe Antiviral Immunoglobulin Sales Quantity by Country (2021-2026) & (kg)
Table 176. Europe Antiviral Immunoglobulin Sales Quantity by Country (2027-2032) & (kg)
Table 177. Europe Antiviral Immunoglobulin Consumption Value by Country (2021-2026) & (USD Million)
Table 178. Europe Antiviral Immunoglobulin Consumption Value by Country (2027-2032) & (USD Million)
Table 179. Asia-Pacific Antiviral Immunoglobulin Sales Quantity by Type (2021-2026) & (kg)
Table 180. Asia-Pacific Antiviral Immunoglobulin Sales Quantity by Type (2027-2032) & (kg)
Table 181. Asia-Pacific Antiviral Immunoglobulin Sales Quantity by Application (2021-2026) & (kg)
Table 182. Asia-Pacific Antiviral Immunoglobulin Sales Quantity by Application (2027-2032) & (kg)
Table 183. Asia-Pacific Antiviral Immunoglobulin Sales Quantity by Region (2021-2026) & (kg)
Table 184. Asia-Pacific Antiviral Immunoglobulin Sales Quantity by Region (2027-2032) & (kg)
Table 185. Asia-Pacific Antiviral Immunoglobulin Consumption Value by Region (2021-2026) & (USD Million)
Table 186. Asia-Pacific Antiviral Immunoglobulin Consumption Value by Region (2027-2032) & (USD Million)
Table 187. South America Antiviral Immunoglobulin Sales Quantity by Type (2021-2026) & (kg)
Table 188. South America Antiviral Immunoglobulin Sales Quantity by Type (2027-2032) & (kg)
Table 189. South America Antiviral Immunoglobulin Sales Quantity by Application (2021-2026) & (kg)
Table 190. South America Antiviral Immunoglobulin Sales Quantity by Application (2027-2032) & (kg)
Table 191. South America Antiviral Immunoglobulin Sales Quantity by Country (2021-2026) & (kg)
Table 192. South America Antiviral Immunoglobulin Sales Quantity by Country (2027-2032) & (kg)
Table 193. South America Antiviral Immunoglobulin Consumption Value by Country (2021-2026) & (USD Million)
Table 194. South America Antiviral Immunoglobulin Consumption Value by Country (2027-2032) & (USD Million)
Table 195. Middle East & Africa Antiviral Immunoglobulin Sales Quantity by Type (2021-2026) & (kg)
Table 196. Middle East & Africa Antiviral Immunoglobulin Sales Quantity by Type (2027-2032) & (kg)
Table 197. Middle East & Africa Antiviral Immunoglobulin Sales Quantity by Application (2021-2026) & (kg)
Table 198. Middle East & Africa Antiviral Immunoglobulin Sales Quantity by Application (2027-2032) & (kg)
Table 199. Middle East & Africa Antiviral Immunoglobulin Sales Quantity by Country (2021-2026) & (kg)
Table 200. Middle East & Africa Antiviral Immunoglobulin Sales Quantity by Country (2027-2032) & (kg)
Table 201. Middle East & Africa Antiviral Immunoglobulin Consumption Value by Country (2021-2026) & (USD Million)
Table 202. Middle East & Africa Antiviral Immunoglobulin Consumption Value by Country (2027-2032) & (USD Million)
Table 203. Antiviral Immunoglobulin Raw Material
Table 204. Key Manufacturers of Antiviral Immunoglobulin Raw Materials
Table 205. Antiviral Immunoglobulin Typical Distributors
Table 206. Antiviral Immunoglobulin Typical Customers
Table 1. Global Antiviral Immunoglobulin Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Antiviral Immunoglobulin Consumption Value by IgG Purity, (USD Million), 2021 & 2025 & 2032
Table 3. Global Antiviral Immunoglobulin Consumption Value by Therapeutic Area, (USD Million), 2021 & 2025 & 2032
Table 4. Global Antiviral Immunoglobulin Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. ADMA Biologics (US) Basic Information, Manufacturing Base and Competitors
Table 6. ADMA Biologics (US) Major Business
Table 7. ADMA Biologics (US) Antiviral Immunoglobulin Product and Services
Table 8. ADMA Biologics (US) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. ADMA Biologics (US) Recent Developments/Updates
Table 10. AstraZeneca (UK/Sweden) Basic Information, Manufacturing Base and Competitors
Table 11. AstraZeneca (UK/Sweden) Major Business
Table 12. AstraZeneca (UK/Sweden) Antiviral Immunoglobulin Product and Services
Table 13. AstraZeneca (UK/Sweden) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. AstraZeneca (UK/Sweden) Recent Developments/Updates
Table 15. Bharat Serums & Vaccines (India) Basic Information, Manufacturing Base and Competitors
Table 16. Bharat Serums & Vaccines (India) Major Business
Table 17. Bharat Serums & Vaccines (India) Antiviral Immunoglobulin Product and Services
Table 18. Bharat Serums & Vaccines (India) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Bharat Serums & Vaccines (India) Recent Developments/Updates
Table 20. Biotest (Germany) Basic Information, Manufacturing Base and Competitors
Table 21. Biotest (Germany) Major Business
Table 22. Biotest (Germany) Antiviral Immunoglobulin Product and Services
Table 23. Biotest (Germany) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Biotest (Germany) Recent Developments/Updates
Table 25. Boya Bio (China) Basic Information, Manufacturing Base and Competitors
Table 26. Boya Bio (China) Major Business
Table 27. Boya Bio (China) Antiviral Immunoglobulin Product and Services
Table 28. Boya Bio (China) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Boya Bio (China) Recent Developments/Updates
Table 30. China Biologic Products (CNBG) (China) Basic Information, Manufacturing Base and Competitors
Table 31. China Biologic Products (CNBG) (China) Major Business
Table 32. China Biologic Products (CNBG) (China) Antiviral Immunoglobulin Product and Services
Table 33. China Biologic Products (CNBG) (China) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. China Biologic Products (CNBG) (China) Recent Developments/Updates
Table 35. CSL Behring (US/Germany) Basic Information, Manufacturing Base and Competitors
Table 36. CSL Behring (US/Germany) Major Business
Table 37. CSL Behring (US/Germany) Antiviral Immunoglobulin Product and Services
Table 38. CSL Behring (US/Germany) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. CSL Behring (US/Germany) Recent Developments/Updates
Table 40. Emergent BioSolutions (US) Basic Information, Manufacturing Base and Competitors
Table 41. Emergent BioSolutions (US) Major Business
Table 42. Emergent BioSolutions (US) Antiviral Immunoglobulin Product and Services
Table 43. Emergent BioSolutions (US) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Emergent BioSolutions (US) Recent Developments/Updates
Table 45. GC Pharma (S. Korea) Basic Information, Manufacturing Base and Competitors
Table 46. GC Pharma (S. Korea) Major Business
Table 47. GC Pharma (S. Korea) Antiviral Immunoglobulin Product and Services
Table 48. GC Pharma (S. Korea) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. GC Pharma (S. Korea) Recent Developments/Updates
Table 50. Grifols (Spain) Basic Information, Manufacturing Base and Competitors
Table 51. Grifols (Spain) Major Business
Table 52. Grifols (Spain) Antiviral Immunoglobulin Product and Services
Table 53. Grifols (Spain) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Grifols (Spain) Recent Developments/Updates
Table 55. Hualan Biological (China) Basic Information, Manufacturing Base and Competitors
Table 56. Hualan Biological (China) Major Business
Table 57. Hualan Biological (China) Antiviral Immunoglobulin Product and Services
Table 58. Hualan Biological (China) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Hualan Biological (China) Recent Developments/Updates
Table 60. Intas Pharmaceuticals (India) Basic Information, Manufacturing Base and Competitors
Table 61. Intas Pharmaceuticals (India) Major Business
Table 62. Intas Pharmaceuticals (India) Antiviral Immunoglobulin Product and Services
Table 63. Intas Pharmaceuticals (India) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Intas Pharmaceuticals (India) Recent Developments/Updates
Table 65. Kamada (Israel) Basic Information, Manufacturing Base and Competitors
Table 66. Kamada (Israel) Major Business
Table 67. Kamada (Israel) Antiviral Immunoglobulin Product and Services
Table 68. Kamada (Israel) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Kamada (Israel) Recent Developments/Updates
Table 70. Kedrion (Italy) Basic Information, Manufacturing Base and Competitors
Table 71. Kedrion (Italy) Major Business
Table 72. Kedrion (Italy) Antiviral Immunoglobulin Product and Services
Table 73. Kedrion (Italy) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Kedrion (Italy) Recent Developments/Updates
Table 75. LFB Group (France) Basic Information, Manufacturing Base and Competitors
Table 76. LFB Group (France) Major Business
Table 77. LFB Group (France) Antiviral Immunoglobulin Product and Services
Table 78. LFB Group (France) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. LFB Group (France) Recent Developments/Updates
Table 80. Octapharma (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 81. Octapharma (Switzerland) Major Business
Table 82. Octapharma (Switzerland) Antiviral Immunoglobulin Product and Services
Table 83. Octapharma (Switzerland) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Octapharma (Switzerland) Recent Developments/Updates
Table 85. Regeneron (US) Basic Information, Manufacturing Base and Competitors
Table 86. Regeneron (US) Major Business
Table 87. Regeneron (US) Antiviral Immunoglobulin Product and Services
Table 88. Regeneron (US) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Regeneron (US) Recent Developments/Updates
Table 90. Roche (Switzerland) Basic Information, Manufacturing Base and Competitors
Table 91. Roche (Switzerland) Major Business
Table 92. Roche (Switzerland) Antiviral Immunoglobulin Product and Services
Table 93. Roche (Switzerland) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. Roche (Switzerland) Recent Developments/Updates
Table 95. Sanofi (France) Basic Information, Manufacturing Base and Competitors
Table 96. Sanofi (France) Major Business
Table 97. Sanofi (France) Antiviral Immunoglobulin Product and Services
Table 98. Sanofi (France) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 99. Sanofi (France) Recent Developments/Updates
Table 100. Shanghai RAAS (China) Basic Information, Manufacturing Base and Competitors
Table 101. Shanghai RAAS (China) Major Business
Table 102. Shanghai RAAS (China) Antiviral Immunoglobulin Product and Services
Table 103. Shanghai RAAS (China) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Shanghai RAAS (China) Recent Developments/Updates
Table 105. Shuanglin Bio (China) Basic Information, Manufacturing Base and Competitors
Table 106. Shuanglin Bio (China) Major Business
Table 107. Shuanglin Bio (China) Antiviral Immunoglobulin Product and Services
Table 108. Shuanglin Bio (China) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Shuanglin Bio (China) Recent Developments/Updates
Table 110. SK Plasma (S. Korea) Basic Information, Manufacturing Base and Competitors
Table 111. SK Plasma (S. Korea) Major Business
Table 112. SK Plasma (S. Korea) Antiviral Immunoglobulin Product and Services
Table 113. SK Plasma (S. Korea) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. SK Plasma (S. Korea) Recent Developments/Updates
Table 115. Takeda Pharmaceutical (Japan) Basic Information, Manufacturing Base and Competitors
Table 116. Takeda Pharmaceutical (Japan) Major Business
Table 117. Takeda Pharmaceutical (Japan) Antiviral Immunoglobulin Product and Services
Table 118. Takeda Pharmaceutical (Japan) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Takeda Pharmaceutical (Japan) Recent Developments/Updates
Table 120. Tiantan Bio (China) Basic Information, Manufacturing Base and Competitors
Table 121. Tiantan Bio (China) Major Business
Table 122. Tiantan Bio (China) Antiviral Immunoglobulin Product and Services
Table 123. Tiantan Bio (China) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 124. Tiantan Bio (China) Recent Developments/Updates
Table 125. Weiguang Biological (China) Basic Information, Manufacturing Base and Competitors
Table 126. Weiguang Biological (China) Major Business
Table 127. Weiguang Biological (China) Antiviral Immunoglobulin Product and Services
Table 128. Weiguang Biological (China) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 129. Weiguang Biological (China) Recent Developments/Updates
Table 130. Yuanda Shuyang (China) Basic Information, Manufacturing Base and Competitors
Table 131. Yuanda Shuyang (China) Major Business
Table 132. Yuanda Shuyang (China) Antiviral Immunoglobulin Product and Services
Table 133. Yuanda Shuyang (China) Antiviral Immunoglobulin Sales Quantity (kg), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 134. Yuanda Shuyang (China) Recent Developments/Updates
Table 135. Global Antiviral Immunoglobulin Sales Quantity by Manufacturer (2021-2026) & (kg)
Table 136. Global Antiviral Immunoglobulin Revenue by Manufacturer (2021-2026) & (USD Million)
Table 137. Global Antiviral Immunoglobulin Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 138. Market Position of Manufacturers in Antiviral Immunoglobulin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 139. Head Office and Antiviral Immunoglobulin Production Site of Key Manufacturer
Table 140. Antiviral Immunoglobulin Market: Company Product Type Footprint
Table 141. Antiviral Immunoglobulin Market: Company Product Application Footprint
Table 142. Antiviral Immunoglobulin New Market Entrants and Barriers to Market Entry
Table 143. Antiviral Immunoglobulin Mergers, Acquisition, Agreements, and Collaborations
Table 144. Global Antiviral Immunoglobulin Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 145. Global Antiviral Immunoglobulin Sales Quantity by Region (2021-2026) & (kg)
Table 146. Global Antiviral Immunoglobulin Sales Quantity by Region (2027-2032) & (kg)
Table 147. Global Antiviral Immunoglobulin Consumption Value by Region (2021-2026) & (USD Million)
Table 148. Global Antiviral Immunoglobulin Consumption Value by Region (2027-2032) & (USD Million)
Table 149. Global Antiviral Immunoglobulin Average Price by Region (2021-2026) & (US$/kg)
Table 150. Global Antiviral Immunoglobulin Average Price by Region (2027-2032) & (US$/kg)
Table 151. Global Antiviral Immunoglobulin Sales Quantity by Type (2021-2026) & (kg)
Table 152. Global Antiviral Immunoglobulin Sales Quantity by Type (2027-2032) & (kg)
Table 153. Global Antiviral Immunoglobulin Consumption Value by Type (2021-2026) & (USD Million)
Table 154. Global Antiviral Immunoglobulin Consumption Value by Type (2027-2032) & (USD Million)
Table 155. Global Antiviral Immunoglobulin Average Price by Type (2021-2026) & (US$/kg)
Table 156. Global Antiviral Immunoglobulin Average Price by Type (2027-2032) & (US$/kg)
Table 157. Global Antiviral Immunoglobulin Sales Quantity by Application (2021-2026) & (kg)
Table 158. Global Antiviral Immunoglobulin Sales Quantity by Application (2027-2032) & (kg)
Table 159. Global Antiviral Immunoglobulin Consumption Value by Application (2021-2026) & (USD Million)
Table 160. Global Antiviral Immunoglobulin Consumption Value by Application (2027-2032) & (USD Million)
Table 161. Global Antiviral Immunoglobulin Average Price by Application (2021-2026) & (US$/kg)
Table 162. Global Antiviral Immunoglobulin Average Price by Application (2027-2032) & (US$/kg)
Table 163. North America Antiviral Immunoglobulin Sales Quantity by Type (2021-2026) & (kg)
Table 164. North America Antiviral Immunoglobulin Sales Quantity by Type (2027-2032) & (kg)
Table 165. North America Antiviral Immunoglobulin Sales Quantity by Application (2021-2026) & (kg)
Table 166. North America Antiviral Immunoglobulin Sales Quantity by Application (2027-2032) & (kg)
Table 167. North America Antiviral Immunoglobulin Sales Quantity by Country (2021-2026) & (kg)
Table 168. North America Antiviral Immunoglobulin Sales Quantity by Country (2027-2032) & (kg)
Table 169. North America Antiviral Immunoglobulin Consumption Value by Country (2021-2026) & (USD Million)
Table 170. North America Antiviral Immunoglobulin Consumption Value by Country (2027-2032) & (USD Million)
Table 171. Europe Antiviral Immunoglobulin Sales Quantity by Type (2021-2026) & (kg)
Table 172. Europe Antiviral Immunoglobulin Sales Quantity by Type (2027-2032) & (kg)
Table 173. Europe Antiviral Immunoglobulin Sales Quantity by Application (2021-2026) & (kg)
Table 174. Europe Antiviral Immunoglobulin Sales Quantity by Application (2027-2032) & (kg)
Table 175. Europe Antiviral Immunoglobulin Sales Quantity by Country (2021-2026) & (kg)
Table 176. Europe Antiviral Immunoglobulin Sales Quantity by Country (2027-2032) & (kg)
Table 177. Europe Antiviral Immunoglobulin Consumption Value by Country (2021-2026) & (USD Million)
Table 178. Europe Antiviral Immunoglobulin Consumption Value by Country (2027-2032) & (USD Million)
Table 179. Asia-Pacific Antiviral Immunoglobulin Sales Quantity by Type (2021-2026) & (kg)
Table 180. Asia-Pacific Antiviral Immunoglobulin Sales Quantity by Type (2027-2032) & (kg)
Table 181. Asia-Pacific Antiviral Immunoglobulin Sales Quantity by Application (2021-2026) & (kg)
Table 182. Asia-Pacific Antiviral Immunoglobulin Sales Quantity by Application (2027-2032) & (kg)
Table 183. Asia-Pacific Antiviral Immunoglobulin Sales Quantity by Region (2021-2026) & (kg)
Table 184. Asia-Pacific Antiviral Immunoglobulin Sales Quantity by Region (2027-2032) & (kg)
Table 185. Asia-Pacific Antiviral Immunoglobulin Consumption Value by Region (2021-2026) & (USD Million)
Table 186. Asia-Pacific Antiviral Immunoglobulin Consumption Value by Region (2027-2032) & (USD Million)
Table 187. South America Antiviral Immunoglobulin Sales Quantity by Type (2021-2026) & (kg)
Table 188. South America Antiviral Immunoglobulin Sales Quantity by Type (2027-2032) & (kg)
Table 189. South America Antiviral Immunoglobulin Sales Quantity by Application (2021-2026) & (kg)
Table 190. South America Antiviral Immunoglobulin Sales Quantity by Application (2027-2032) & (kg)
Table 191. South America Antiviral Immunoglobulin Sales Quantity by Country (2021-2026) & (kg)
Table 192. South America Antiviral Immunoglobulin Sales Quantity by Country (2027-2032) & (kg)
Table 193. South America Antiviral Immunoglobulin Consumption Value by Country (2021-2026) & (USD Million)
Table 194. South America Antiviral Immunoglobulin Consumption Value by Country (2027-2032) & (USD Million)
Table 195. Middle East & Africa Antiviral Immunoglobulin Sales Quantity by Type (2021-2026) & (kg)
Table 196. Middle East & Africa Antiviral Immunoglobulin Sales Quantity by Type (2027-2032) & (kg)
Table 197. Middle East & Africa Antiviral Immunoglobulin Sales Quantity by Application (2021-2026) & (kg)
Table 198. Middle East & Africa Antiviral Immunoglobulin Sales Quantity by Application (2027-2032) & (kg)
Table 199. Middle East & Africa Antiviral Immunoglobulin Sales Quantity by Country (2021-2026) & (kg)
Table 200. Middle East & Africa Antiviral Immunoglobulin Sales Quantity by Country (2027-2032) & (kg)
Table 201. Middle East & Africa Antiviral Immunoglobulin Consumption Value by Country (2021-2026) & (USD Million)
Table 202. Middle East & Africa Antiviral Immunoglobulin Consumption Value by Country (2027-2032) & (USD Million)
Table 203. Antiviral Immunoglobulin Raw Material
Table 204. Key Manufacturers of Antiviral Immunoglobulin Raw Materials
Table 205. Antiviral Immunoglobulin Typical Distributors
Table 206. Antiviral Immunoglobulin Typical Customers
LIST OF FIGURES
Figure 1. Antiviral Immunoglobulin Picture
Figure 2. Global Antiviral Immunoglobulin Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Antiviral Immunoglobulin Revenue Market Share by Type in 2025
Figure 4. Human Plasma Derived Polyclonal Examples
Figure 5. Hyperimmune Specific Globulin Examples
Figure 6. Recombinant Monoclonal Antibody (mAb) Examples
Figure 7. Animal Derived (Equine/Ovine) Examples
Figure 8. Others Examples
Figure 9. Global Antiviral Immunoglobulin Revenue by IgG Purity, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Antiviral Immunoglobulin Revenue Market Share by IgG Purity in 2025
Figure 11. Standard Fractionated Grade (90%–95%) Examples
Figure 12. Clinical High Purity Grade (96%–98%) Examples
Figure 13. Ultra Purified Specialty Grade(99%) Examples
Figure 14. Global Antiviral Immunoglobulin Revenue by Therapeutic Area, (USD Million), 2021 & 2025 & 2032
Figure 15. Global Antiviral Immunoglobulin Revenue Market Share by Therapeutic Area in 2025
Figure 16. Transplantation Examples
Figure 17. Infectious Disease Prophylaxis Examples
Figure 18. Immunodeficiency Examples
Figure 19. Neurology (Autoimmune) Examples
Figure 20. Others Examples
Figure 21. Global Antiviral Immunoglobulin Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 22. Global Antiviral Immunoglobulin Revenue Market Share by Application in 2025
Figure 23. Hospitals Examples
Figure 24. Specialty Clinics Examples
Figure 25. Home Care Examples
Figure 26. Others Examples
Figure 27. Global Antiviral Immunoglobulin Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 28. Global Antiviral Immunoglobulin Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 29. Global Antiviral Immunoglobulin Sales Quantity (2021-2032) & (kg)
Figure 30. Global Antiviral Immunoglobulin Price (2021-2032) & (US$/kg)
Figure 31. Global Antiviral Immunoglobulin Sales Quantity Market Share by Manufacturer in 2025
Figure 32. Global Antiviral Immunoglobulin Revenue Market Share by Manufacturer in 2025
Figure 33. Producer Shipments of Antiviral Immunoglobulin by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 34. Top 3 Antiviral Immunoglobulin Manufacturer (Revenue) Market Share in 2025
Figure 35. Top 6 Antiviral Immunoglobulin Manufacturer (Revenue) Market Share in 2025
Figure 36. Global Antiviral Immunoglobulin Sales Quantity Market Share by Region (2021-2032)
Figure 37. Global Antiviral Immunoglobulin Consumption Value Market Share by Region (2021-2032)
Figure 38. North America Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 39. Europe Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 40. Asia-Pacific Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 41. South America Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 42. Middle East & Africa Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 43. Global Antiviral Immunoglobulin Sales Quantity Market Share by Type (2021-2032)
Figure 44. Global Antiviral Immunoglobulin Consumption Value Market Share by Type (2021-2032)
Figure 45. Global Antiviral Immunoglobulin Average Price by Type (2021-2032) & (US$/kg)
Figure 46. Global Antiviral Immunoglobulin Sales Quantity Market Share by Application (2021-2032)
Figure 47. Global Antiviral Immunoglobulin Revenue Market Share by Application (2021-2032)
Figure 48. Global Antiviral Immunoglobulin Average Price by Application (2021-2032) & (US$/kg)
Figure 49. North America Antiviral Immunoglobulin Sales Quantity Market Share by Type (2021-2032)
Figure 50. North America Antiviral Immunoglobulin Sales Quantity Market Share by Application (2021-2032)
Figure 51. North America Antiviral Immunoglobulin Sales Quantity Market Share by Country (2021-2032)
Figure 52. North America Antiviral Immunoglobulin Consumption Value Market Share by Country (2021-2032)
Figure 53. United States Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 54. Canada Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 55. Mexico Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 56. Europe Antiviral Immunoglobulin Sales Quantity Market Share by Type (2021-2032)
Figure 57. Europe Antiviral Immunoglobulin Sales Quantity Market Share by Application (2021-2032)
Figure 58. Europe Antiviral Immunoglobulin Sales Quantity Market Share by Country (2021-2032)
Figure 59. Europe Antiviral Immunoglobulin Consumption Value Market Share by Country (2021-2032)
Figure 60. Germany Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 61. France Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 62. United Kingdom Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 63. Russia Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 64. Italy Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 65. Asia-Pacific Antiviral Immunoglobulin Sales Quantity Market Share by Type (2021-2032)
Figure 66. Asia-Pacific Antiviral Immunoglobulin Sales Quantity Market Share by Application (2021-2032)
Figure 67. Asia-Pacific Antiviral Immunoglobulin Sales Quantity Market Share by Region (2021-2032)
Figure 68. Asia-Pacific Antiviral Immunoglobulin Consumption Value Market Share by Region (2021-2032)
Figure 69. China Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 70. Japan Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 71. South Korea Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 72. India Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 73. Southeast Asia Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 74. Australia Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 75. South America Antiviral Immunoglobulin Sales Quantity Market Share by Type (2021-2032)
Figure 76. South America Antiviral Immunoglobulin Sales Quantity Market Share by Application (2021-2032)
Figure 77. South America Antiviral Immunoglobulin Sales Quantity Market Share by Country (2021-2032)
Figure 78. South America Antiviral Immunoglobulin Consumption Value Market Share by Country (2021-2032)
Figure 79. Brazil Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 80. Argentina Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 81. Middle East & Africa Antiviral Immunoglobulin Sales Quantity Market Share by Type (2021-2032)
Figure 82. Middle East & Africa Antiviral Immunoglobulin Sales Quantity Market Share by Application (2021-2032)
Figure 83. Middle East & Africa Antiviral Immunoglobulin Sales Quantity Market Share by Country (2021-2032)
Figure 84. Middle East & Africa Antiviral Immunoglobulin Consumption Value Market Share by Country (2021-2032)
Figure 85. Turkey Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 86. Egypt Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 87. Saudi Arabia Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 88. South Africa Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 89. Antiviral Immunoglobulin Market Drivers
Figure 90. Antiviral Immunoglobulin Market Restraints
Figure 91. Antiviral Immunoglobulin Market Trends
Figure 92. Porters Five Forces Analysis
Figure 93. Manufacturing Cost Structure Analysis of Antiviral Immunoglobulin in 2025
Figure 94. Manufacturing Process Analysis of Antiviral Immunoglobulin
Figure 95. Antiviral Immunoglobulin Industrial Chain
Figure 96. Sales Channel: Direct to End-User vs Distributors
Figure 97. Direct Channel Pros & Cons
Figure 98. Indirect Channel Pros & Cons
Figure 99. Methodology
Figure 100. Research Process and Data Source
Figure 1. Antiviral Immunoglobulin Picture
Figure 2. Global Antiviral Immunoglobulin Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Antiviral Immunoglobulin Revenue Market Share by Type in 2025
Figure 4. Human Plasma Derived Polyclonal Examples
Figure 5. Hyperimmune Specific Globulin Examples
Figure 6. Recombinant Monoclonal Antibody (mAb) Examples
Figure 7. Animal Derived (Equine/Ovine) Examples
Figure 8. Others Examples
Figure 9. Global Antiviral Immunoglobulin Revenue by IgG Purity, (USD Million), 2021 & 2025 & 2032
Figure 10. Global Antiviral Immunoglobulin Revenue Market Share by IgG Purity in 2025
Figure 11. Standard Fractionated Grade (90%–95%) Examples
Figure 12. Clinical High Purity Grade (96%–98%) Examples
Figure 13. Ultra Purified Specialty Grade(99%) Examples
Figure 14. Global Antiviral Immunoglobulin Revenue by Therapeutic Area, (USD Million), 2021 & 2025 & 2032
Figure 15. Global Antiviral Immunoglobulin Revenue Market Share by Therapeutic Area in 2025
Figure 16. Transplantation Examples
Figure 17. Infectious Disease Prophylaxis Examples
Figure 18. Immunodeficiency Examples
Figure 19. Neurology (Autoimmune) Examples
Figure 20. Others Examples
Figure 21. Global Antiviral Immunoglobulin Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 22. Global Antiviral Immunoglobulin Revenue Market Share by Application in 2025
Figure 23. Hospitals Examples
Figure 24. Specialty Clinics Examples
Figure 25. Home Care Examples
Figure 26. Others Examples
Figure 27. Global Antiviral Immunoglobulin Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 28. Global Antiviral Immunoglobulin Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 29. Global Antiviral Immunoglobulin Sales Quantity (2021-2032) & (kg)
Figure 30. Global Antiviral Immunoglobulin Price (2021-2032) & (US$/kg)
Figure 31. Global Antiviral Immunoglobulin Sales Quantity Market Share by Manufacturer in 2025
Figure 32. Global Antiviral Immunoglobulin Revenue Market Share by Manufacturer in 2025
Figure 33. Producer Shipments of Antiviral Immunoglobulin by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 34. Top 3 Antiviral Immunoglobulin Manufacturer (Revenue) Market Share in 2025
Figure 35. Top 6 Antiviral Immunoglobulin Manufacturer (Revenue) Market Share in 2025
Figure 36. Global Antiviral Immunoglobulin Sales Quantity Market Share by Region (2021-2032)
Figure 37. Global Antiviral Immunoglobulin Consumption Value Market Share by Region (2021-2032)
Figure 38. North America Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 39. Europe Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 40. Asia-Pacific Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 41. South America Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 42. Middle East & Africa Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 43. Global Antiviral Immunoglobulin Sales Quantity Market Share by Type (2021-2032)
Figure 44. Global Antiviral Immunoglobulin Consumption Value Market Share by Type (2021-2032)
Figure 45. Global Antiviral Immunoglobulin Average Price by Type (2021-2032) & (US$/kg)
Figure 46. Global Antiviral Immunoglobulin Sales Quantity Market Share by Application (2021-2032)
Figure 47. Global Antiviral Immunoglobulin Revenue Market Share by Application (2021-2032)
Figure 48. Global Antiviral Immunoglobulin Average Price by Application (2021-2032) & (US$/kg)
Figure 49. North America Antiviral Immunoglobulin Sales Quantity Market Share by Type (2021-2032)
Figure 50. North America Antiviral Immunoglobulin Sales Quantity Market Share by Application (2021-2032)
Figure 51. North America Antiviral Immunoglobulin Sales Quantity Market Share by Country (2021-2032)
Figure 52. North America Antiviral Immunoglobulin Consumption Value Market Share by Country (2021-2032)
Figure 53. United States Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 54. Canada Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 55. Mexico Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 56. Europe Antiviral Immunoglobulin Sales Quantity Market Share by Type (2021-2032)
Figure 57. Europe Antiviral Immunoglobulin Sales Quantity Market Share by Application (2021-2032)
Figure 58. Europe Antiviral Immunoglobulin Sales Quantity Market Share by Country (2021-2032)
Figure 59. Europe Antiviral Immunoglobulin Consumption Value Market Share by Country (2021-2032)
Figure 60. Germany Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 61. France Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 62. United Kingdom Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 63. Russia Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 64. Italy Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 65. Asia-Pacific Antiviral Immunoglobulin Sales Quantity Market Share by Type (2021-2032)
Figure 66. Asia-Pacific Antiviral Immunoglobulin Sales Quantity Market Share by Application (2021-2032)
Figure 67. Asia-Pacific Antiviral Immunoglobulin Sales Quantity Market Share by Region (2021-2032)
Figure 68. Asia-Pacific Antiviral Immunoglobulin Consumption Value Market Share by Region (2021-2032)
Figure 69. China Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 70. Japan Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 71. South Korea Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 72. India Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 73. Southeast Asia Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 74. Australia Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 75. South America Antiviral Immunoglobulin Sales Quantity Market Share by Type (2021-2032)
Figure 76. South America Antiviral Immunoglobulin Sales Quantity Market Share by Application (2021-2032)
Figure 77. South America Antiviral Immunoglobulin Sales Quantity Market Share by Country (2021-2032)
Figure 78. South America Antiviral Immunoglobulin Consumption Value Market Share by Country (2021-2032)
Figure 79. Brazil Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 80. Argentina Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 81. Middle East & Africa Antiviral Immunoglobulin Sales Quantity Market Share by Type (2021-2032)
Figure 82. Middle East & Africa Antiviral Immunoglobulin Sales Quantity Market Share by Application (2021-2032)
Figure 83. Middle East & Africa Antiviral Immunoglobulin Sales Quantity Market Share by Country (2021-2032)
Figure 84. Middle East & Africa Antiviral Immunoglobulin Consumption Value Market Share by Country (2021-2032)
Figure 85. Turkey Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 86. Egypt Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 87. Saudi Arabia Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 88. South Africa Antiviral Immunoglobulin Consumption Value (2021-2032) & (USD Million)
Figure 89. Antiviral Immunoglobulin Market Drivers
Figure 90. Antiviral Immunoglobulin Market Restraints
Figure 91. Antiviral Immunoglobulin Market Trends
Figure 92. Porters Five Forces Analysis
Figure 93. Manufacturing Cost Structure Analysis of Antiviral Immunoglobulin in 2025
Figure 94. Manufacturing Process Analysis of Antiviral Immunoglobulin
Figure 95. Antiviral Immunoglobulin Industrial Chain
Figure 96. Sales Channel: Direct to End-User vs Distributors
Figure 97. Direct Channel Pros & Cons
Figure 98. Indirect Channel Pros & Cons
Figure 99. Methodology
Figure 100. Research Process and Data Source
